To Succeed With Return To Office, Focus On These 3 Wellness Strategies
JPMorgan, Amazon, and others are enforcing return to office mandates. Here are 3 wellness strategies to help companies ease ...
GlobalData on MSN23h
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
Big bank CEOs can't wait for Trump. Here's what they're saying
The biggest U.S. banks reported earnings this week, and the companies’ top leadership didn’t shy away from addressing the ...
Stock market today: Nasdaq slide leads stocks lower with earnings, Bessent confirmation hearing in focus
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/98.YCWzV16B.js ...
Citigroup Earnings: Firm Remains in a Turnaround
Citigroup C ended the year with middling numbers, but its upbeat management guidance for 2025 and announcement of a $20 ...
Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely
Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...
Earnings call transcript: U.S. Bancorp beats Q3 2024 EPS forecast, stock rises
U.S. Bancorp (BVMF:USBC34) (USB) reported better-than-expected earnings for the third quarter of 2024, with a diluted earnings per share (EPS) of $1.07, surpassing the forecast of $1.05. The company's ...